Literature DB >> 16242338

Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.

Apiwat Baramee1, Alexandra Coppin, Marlène Mortuaire, Lydie Pelinski, Stanislas Tomavo, Jacques Brocard.   

Abstract

Fourteen ferrocenyl aminohydroxynaphthoquinones, analogues of atovaquone, were synthesized from the hydroxynaphthoquinone core. These novel atovaquone derivatives were tested for their in vitro activity against two apicomplexan parasites of medical importance, Toxoplasma gondii and Plasmodium falciparum, including resistant strains to atovaquone (T. gondii) and chloroquine (P. falciparum). Three of these ferrocenic atovaquone derivatives composed of the hydroxynaphthoquinone core plus an amino-ferrocenic group and an aliphatic chain with 6-8 carbon atoms were found to be significantly active against T. gondii. Moreover, these novel compounds were also effective against the atovaquone-resistant strain of T. gondii (Ato(R)).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242338     DOI: 10.1016/j.bmc.2005.09.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Probing binding determinants in center P of the cytochrome bc(1) complex using novel hydroxy-naphthoquinones.

Authors:  Louise M Hughes; Raul Covian; Gordon W Gribble; Bernard L Trumpower
Journal:  Biochim Biophys Acta       Date:  2009-08-04

2.  Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.

Authors:  Eliane de Oliveira Silva; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

Review 3.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 4.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

5.  N-(Ferrocenylmethyl)-dodecan-1-amine.

Authors:  Li-Zhen Sun; Wei An; Hua-Cheng Zhang; Fei-Fei Xin; Ai-You Hao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-13

6.  Synthesis, SAR, and Docking Studies Disclose 2-Arylfuran-1,4-naphthoquinones as In Vitro Antiplasmodial Hits.

Authors:  Tatiane Freitas Borgati; Maria Fernanda Alves do Nascimento; Juma Fortunato Bernardino; Lunamaura Claudia Oliveira Martins; Alex Gutterres Taranto; Alaíde Braga de Oliveira
Journal:  J Trop Med       Date:  2017-10-31

Review 7.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

8.  Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.

Authors:  Péter Bárány; Rita Szabó Oláh; Imre Kovács; Tamás Czuczi; Csenge Lilla Szabó; Angéla Takács; Eszter Lajkó; Orsolya Láng; László Kőhidai; Gitta Schlosser; Szilvia Bősze; Gábor Mező; Ferenc Hudecz; Antal Csámpai
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

Review 9.  Ferroquine and its derivatives: new generation of antimalarial agents.

Authors:  Waseem A Wani; Ehtesham Jameel; Umair Baig; Syed Mumtazuddin; Lee Ting Hun
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

10.  Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.

Authors:  Christine N Morrison; Kathleen E Prosser; Ryjul W Stokes; Anna Cordes; Nils Metzler-Nolte; Seth M Cohen
Journal:  Chem Sci       Date:  2019-12-12       Impact factor: 9.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.